Avsola

What Avsola is used for

The FDA lists the approved uses on the official label (below). In the EU, infliximab is approved as Remicade for:

Rheumatoid arthritis Remicade, in combination with methotrexate, is indicated for the reduction of signs and symptoms as well as the improvement in physical function in: adult patients with active disease when the response to disease-modifying antirheumatic drugs (DMARDs), including methotrexate, has been inadequate; adult patients with severe, active and progressive disease not previously treated with methotrexate or other DMARDs. In these patient populations, a reduction in the rate of the progression of joint damage, as measured by X-ray, has been demonstrated. Adult Crohn's disease Remicade is indicated for: treatment of moderately to severely active Crohn's disease, in adult patients who have not responded despite a full and adequate course of therapy with a corticosteroid and / or an immunosuppressant; or who are intolerant to or have medical contraindications for such therapies; t…

EU wording from the European Medicines Agency; US approved uses can differ.

Key facts

Brand

Avsola

Generic name

Infliximab-axxq

Made by

Amgen, Inc

Forms

Injection, Powder, Lyophilized, For Solution

Given

Intravenous

Drug class

Tumor Necrosis Factor Blocker

FDA approval

Biologic licence (BLA) BLA761086

On the US market since

2019

Official information

• Avsola prescribing information (FDA label) on DailyMed
• MedlinePlus drug information (search for Infliximab-axxq)

In India

• Infliximab: 2 brands in India